Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 26 peer-reviewed journal articles Updated
Neurology · Autoimmune Encephalitis

How Is Seronegative Autoimmune Encephalitis Distinguished?

At a Glance

Seronegative autoimmune encephalitis cannot be ruled out by a negative antibody test or a normal MRI, EEG, or spinal fluid result. Doctors combine the rapid symptom pattern with exam and tests while checking for infection, seizures, medication effects, metabolic disease, and psychiatric illness.

In this answer

6 sections

01

The Timeline of Symptoms

02

Medical History and Substance Review

03

The Neurologic and Cognitive Exam

04

Laboratory, Imaging, and Spinal Fluid Tests

05

Ruling Out Associated Tumors

06

The Role of an Immunotherapy Trial

Being told your antibody tests are negative when you or a loved one are experiencing severe confusion or neurological symptoms can be an emotionally overwhelming burden. Seronegative autoimmune encephalitis (AE) is not diagnosed by a single definitive test. Instead, doctors use a “syndrome-based approach.” This means they look for a compatible pattern of symptoms and supportive test results, while systematically investigating and ruling out alternative causes [1].

“Seronegative” simply means that no currently recognized antibody was detected using standard testing panels—it does not prove that an autoimmune condition is absent [1]. Because diagnosing this condition involves carefully navigating many possibilities, doctors combine a detailed symptom timeline with objective findings from brain imaging, brainwave tests, and spinal fluid analysis [2].

⚠️ URGENT CARE WARNING:
Rapidly worsening confusion, a new seizure, an inability to awaken, fever with altered mental status, or marked loss of consciousness requires emergency medical assessment. Conditions that mimic AE, such as infectious encephalitis or nonconvulsive status epilepticus (hidden seizures), can be life-threatening and require immediate treatment, even while other tests are pending [3][4].

The Timeline of Symptoms

A critical clue is how quickly symptoms develop. Autoimmune encephalitis typically causes an acute to subacute onset—meaning symptoms develop suddenly and progress over days to a few weeks [5]. This might include rapid cognitive decline, extreme behavioral changes, altered consciousness, or new seizures [6]. In contrast, symptoms that develop very slowly over many months or years are less likely to be autoimmune encephalitis and may point toward a different neurological or psychiatric condition [7]. It is highly recommended to bring a trusted caregiver to appointments who can provide an accurate timeline of these events.

Medical History and Substance Review

To ensure symptoms aren’t caused by medication toxicity (harmful effects from drugs) or withdrawal, the medical team conducts a rigorous review of all prescription medications, over-the-counter drugs, supplements, and recreational substances [8]. Some medications can cause severe confusion or organ dysfunction that affects the brain, which can mimic encephalitis [9].

The Neurologic and Cognitive Exam

Distinguishing AE from a primary psychiatric illness requires a careful neurologic exam. While psychiatric disorders share symptoms like hallucinations, AE often presents with physical “red flags” that increase concern and warrant urgent medical evaluation [5]. These include catatonia (a state where a person may be unresponsive or hold rigid postures), abnormal movements, difficulty speaking, or severe confusion [10]. While these physical neurological signs can occasionally occur in psychiatric disorders, their sudden appearance strongly points to the need for a thorough neurological workup [5].

Laboratory, Imaging, and Spinal Fluid Tests

To evaluate for metabolic disease, genetic issues, and infections, doctors use a battery of objective tests. Routine blood work helps identify common toxic-metabolic or organ-related problems, which may prompt more targeted testing [11].

What Each Test Can and Cannot Tell You

Test What it can show Important Limitations Does a normal result rule out AE?
Spinal Fluid Analysis (CSF) Elevated white cells (pleocytosis) or oligoclonal bands (immune proteins produced in the spinal fluid) support the presence of inflammation [12]. Critically, the CSF is also used to test for infections like Herpes Simplex Virus [13]. Findings like oligoclonal bands are not specific to AE and can occur in other conditions. No. Normal CSF can occur in confirmed cases of AE [14].
Brain Imaging (MRI) Can identify areas of brain swelling or inflammation [14]. Swelling does not absolutely confirm AE, and an MRI cannot definitively rule out every possible stroke, tumor, or mimic [15]. No. Many cases of AE present with a completely normal MRI [16].
Brainwave Testing (EEG) Can detect hidden seizures and wide-spread brain slowing [4]. Slowing is non-specific. A short routine EEG may miss intermittent seizures, so a prolonged video EEG may be needed [17]. No.
Antibody Testing Checks blood and spinal fluid using cell-based and tissue-based assays (methods used to detect if antibodies bind to specific cells or brain tissues) [18]. “Seronegative” only means no recognized antibody was found on the panel used. It does not ensure the absence of an autoimmune response [1]. No.

Ruling Out Associated Tumors

Because some forms of autoimmune encephalitis are paraneoplastic (triggered by the immune system reacting to an associated tumor), your doctor may order body scans [19]. Screening is individualized based on age, sex, and symptoms [20]. For example, finding an ovarian teratoma (a specific type of ovarian tumor) or a thymoma (a tumor in the thymus gland) can support a paraneoplastic explanation and will change your medical management, as treating the tumor is critical [19][21]. However, finding a tumor does not independently establish AE, as it could be incidental, and repeat screening may be discussed if suspicion remains high over time [20].

The Role of an Immunotherapy Trial

If the clinical picture strongly points to autoimmune encephalitis and critical mimics—especially infections—have been reasonably addressed, doctors may start a short course of immunotherapy even while some test results are pending [22]. This may include high-dose steroids or IVIG (Intravenous Immunoglobulin, a treatment made of pooled antibodies that helps regulate the immune system) [23].

It is important to know that while clinical improvement after immunotherapy supports the diagnosis of AE, it does not independently prove it [24]. Patients may sometimes improve due to natural spontaneous recovery, the treatment of an overlapping mimic, or non-specific effects of the concurrent hospital care [23]. Because long-term immunotherapy carries risks of infection and other side effects, your medical team will carefully track objective clinical improvements—such as cognition, behavior, and seizure control—rather than just waiting for changes on an MRI or EEG [25][26].

Common questions in this guide

Can a negative antibody test rule out autoimmune encephalitis?
No. A negative result means that no currently recognized antibody was found on the blood or spinal fluid panel used; it does not prove that an autoimmune process is absent. Doctors also consider the symptom pattern, examination, imaging, EEG, spinal fluid findings, and other causes.
How do doctors tell autoimmune encephalitis apart from seizures?
Seizures can be a symptom of autoimmune encephalitis, so the conditions can overlap. An EEG can identify ongoing or hidden seizures, and prolonged video EEG may be needed when a short test misses intermittent events. Doctors also look for the broader pattern of rapid cognitive or behavioral change and other neurologic signs.
What tests help find the cause of rapidly changing confusion?
Doctors may use blood tests, medication and substance review, brain MRI, EEG, and spinal fluid analysis. Spinal fluid can show inflammation and can be tested for infections, while EEG can detect hidden seizures. No single normal test, including a normal MRI, EEG, or spinal fluid result, reliably rules out autoimmune encephalitis.
Which features make autoimmune encephalitis more concerning than a psychiatric illness?
A sudden or rapidly progressive change with severe confusion, catatonia, abnormal movements, difficulty speaking, altered consciousness, or new seizures calls for a neurologic evaluation. These signs can occasionally occur in psychiatric disorders, but their sudden appearance is a reason to investigate medical and neurologic causes urgently. A psychiatric diagnosis should not be made from symptoms alone when these red flags are present.
Can steroids or IVIG prove that someone has autoimmune encephalitis?
No. Improvement after immunotherapy such as high-dose steroids or IVIG can support the diagnosis, but it does not prove it. People may improve because of spontaneous recovery, treatment of another condition, or general hospital care, so clinicians track objective changes such as cognition, behavior, and seizure control.
When is possible autoimmune encephalitis an emergency?
Rapidly worsening confusion, a new seizure, inability to awaken, fever with altered mental status, or marked loss of consciousness requires emergency medical assessment. Serious conditions such as infectious encephalitis and nonconvulsive status epilepticus can look similar and need prompt treatment. Do not wait for antibody results before seeking urgent care.

Related questions

Is Blood or CSF Better for Autoimmune Encephalitis? What Does CSF Show in Seronegative Autoimmune Encephalitis? Can Seronegative Encephalitis Have Normal MRI, CSF, EEG? How Can Autoimmune Encephalitis Happen Without Antibodies? Why Do Symptoms Fluctuate in Autoimmune Encephalitis?
Show more
Why Rule Out Infection Before Autoimmune Encephalitis? Can Seronegative Autoimmune Encephalitis Develop Slowly? Seronegative Autoimmune Encephalitis: Need a Brain Biopsy? Can Seronegative AE Cause Psychosis Without Seizures? Can Prior Treatments Cause False-Negative Antibody Tests? Can Seronegative Autoimmune Encephalitis Cause Symptoms? When Should Seronegative Encephalitis Treatment Begin? Seronegative AE: Is Cancer Screening Needed for Me? Should Autoimmune Encephalitis Antibody Tests Be Repeated? What Does Seronegative Autoimmune Encephalitis Mean? Seronegative vs Antibody-Positive AE: Is Prognosis Worse? What Seizure Types Occur in Seronegative Autoimmune Encephalitis? When Is FDG-PET Useful After Negative MRI and Antibodies? Why Is Prolonged EEG Needed in Seronegative Encephalitis?

Get notified when new evidence is published on Non-specific autoimmune supratentorial encephalitis without characteristic antibodies.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (26)
  1. 1

    Diagnostic criteria for autoimmune encephalitis: utility and pitfalls for antibody-negative disease.

    Dalmau J, Graus F

    The Lancet. Neurology 2023; (22(6)):529-540 doi:10.1016/S1474-4422(23)00083-2.

    PMID: 37210100
  2. 2

    Diagnosing autoimmune encephalitis in psychiatry: clinical recommendations and unresolved challenges from the GENERATE network.

    Endres D, von Zedtwitz K, Tebartz van Elst L, et al.

    Molecular psychiatry 2026; doi:10.1038/s41380-026-03871-2.

    PMID: 42786262
  3. 3

    Differential diagnosis and comparison of diagnostic algorithms in children and adolescents with autoimmune encephalitis in Spain: a prospective cohort study and retrospective analysis.

    Olivé-Cirera G, Fonseca E, Chen LW, et al.

    The Lancet. Neurology 2025; (24(1)):54-64 doi:10.1016/S1474-4422(24)00443-5.

    PMID: 39706634
  4. 4

    The Clinical Significance of Abnormal Electroencephalography (EEG) Patterns in Patients with Neuropsychiatric Disorders Due to Anti-NMDA Receptor Encephalitis: A Comparative Study.

    Moreno-Avellán A, Juarez-Jaramillo A, Fernandez Gonzalez-Aragon MDC, et al.

    Diagnostics (Basel, Switzerland) 2025; (15(9)) doi:10.3390/diagnostics15091131.

    PMID: 40361949
  5. 5

    Autoimmune encephalitis and paraneoplastic neurologic syndrome: clinical diagnosis.

    Lee ST

    Current opinion in neurology 2026; (39(3)):361-369 doi:10.1097/WCO.0000000000001489.

    PMID: 41934148
  6. 6

    Clinical features and outcomes of paediatric probable antibody-negative autoimmune encephalitis.

    Kim HJ, Cha JH, Kim W, et al.

    Developmental medicine and child neurology 2026; (68(4)):549-557 doi:10.1111/dmcn.16456.

    PMID: 40751942
  7. 7

    Autoimmune Encephalitis Misdiagnosis in Adults.

    Flanagan EP, Geschwind MD, Lopez-Chiriboga AS, et al.

    JAMA neurology 2023; (80(1)):30-39 doi:10.1001/jamaneurol.2022.4251.

    PMID: 36441519
  8. 8

    Genetic or Autoimmune: POLG-Related Epilepsy Initially Treated as an Autoimmune Encephalitis, a Case Report.

    Shah S, Berezoski A, Rahman S, et al.

    The Neurohospitalist 2021; (11(1)):80-83 doi:10.1177/1941874420952263.

    PMID: 33868564
  9. 9

    Clinical Reasoning: A 66-Year-Old Female Patient With Rapidly Progressive Memory Changes.

    Fokas JA, Guo K, Mejia Bautista M, et al.

    Neurology 2025; (105(8)):e214211 doi:10.1212/WNL.0000000000214211.

    PMID: 41004696
  10. 10

    Abnormal Magnetic Resonance Imaging Patterns in Patients with Neuropsychiatric Disorders Due to Anti-NMDA Receptor Encephalitis: A Comparative Study.

    Restrepo-Martinez M, Carrillo-Mezo R, Medina-Islas A, et al.

    Diagnostics (Basel, Switzerland) 2026; (16(3)) doi:10.3390/diagnostics16030391.

    PMID: 41681709
  11. 11

    Clinical implications of free triiodothyronine levels and diagnostic revisions in antibody-negative autoimmune encephalitis.

    Fang T, He X, Chen J, et al.

    Frontiers in immunology 2026; (17()):1847846 doi:10.3389/fimmu.2026.1847846.

    PMID: 42483187
  12. 12

    Aseptic Encephalitis in an Immunocompetent Young Adult: A Case Report.

    Saldaña Solano AJ, Carrillo Loza K, Benítez Valenzuela J, Rangel López E

    Cureus 2025; (17(8)):e89821 doi:10.7759/cureus.89821.

    PMID: 40937263
  13. 13

    Seronegative Autoimmune Encephalitis: A Case Report and Literature Review.

    Fierro C, Laurienzo A, Cuzzone V

    Cureus 2026; (18(3)):e105381 doi:10.7759/cureus.105381.

    PMID: 42005155
  14. 14

    [Clinical features and long-term prognosis of probable antibody-negative autoimmune encephalitis in children].

    Wu HH, Chen JX, Liu S, et al.

    Zhonghua er ke za zhi = Chinese journal of pediatrics 2026; (64(7)):809-814 doi:10.3760/cma.j.cn112140-20260227-00161.

    PMID: 42298856
  15. 15

    EEG Contribution to the Diagnosis of Antibody-Negative Autoimmune Encephalitis: A Case Report.

    Mito M, Sakurai K, Nakamura Y, et al.

    Case reports in neurology 2021; (13(3)):739-743 doi:10.1159/000519991.

    PMID: 35082642
  16. 16

    MRI findings in autoimmune encephalitis.

    Hartung TJ, Bartels F, Kuchling J, et al.

    Revue neurologique 2024; (180(9)):895-907 doi:10.1016/j.neurol.2024.08.006.

    PMID: 39358087
  17. 17

    Utility of Neurodiagnostic Studies in the Diagnosis of Autoimmune Encephalitis in Children.

    Albert DV, Pluto CP, Weber A, et al.

    Pediatric neurology 2016; (55()):37-45.

    PMID: 26724889
  18. 18

    Neural Antibody Testing in Patients with Suspected Autoimmune Encephalitis.

    Budhram A, Dubey D, Sechi E, et al.

    Clinical chemistry 2020; (66(12)):1496-1509 doi:10.1093/clinchem/hvaa254.

    PMID: 33221892
  19. 19

    The Diagnosis and Treatment of Autoimmune Encephalitis.

    Lancaster E

    Journal of clinical neurology (Seoul, Korea) 2016; (12(1)):1-13 doi:10.3988/jcn.2016.12.1.1.

    PMID: 26754777
  20. 20

    Autoimmune encephalitis: proposed recommendations for symptomatic and long-term management.

    Abboud H, Probasco J, Irani SR, et al.

    Journal of neurology, neurosurgery, and psychiatry 2021; doi:10.1136/jnnp-2020-325302.

    PMID: 33649021
  21. 21

    Thymoma-associated autoimmune encephalitis: Analysis of factors determining prognosis.

    Song W, Li K, Li J, et al.

    CNS neuroscience & therapeutics 2023; (29(5)):1213-1221 doi:10.1111/cns.14166.

    PMID: 36914970
  22. 22

    A clinical approach to diagnosis of autoimmune encephalitis.

    Graus F, Titulaer MJ, Balu R, et al.

    The Lancet. Neurology 2016; (15(4)):391-404.

    PMID: 26906964
  23. 23

    The safety and efficacy of intravenous immunoglobulin in autoimmune encephalitis.

    Lee ST, Lee HS, Lee WJ, et al.

    Annals of clinical and translational neurology 2022; (9(5)):610-621 doi:10.1002/acn3.51540.

    PMID: 35315247
  24. 24

    Suspected autoimmune encephalitis: A retrospective study of patients referred for therapeutic plasma exchange.

    Crowe EP, Diaz-Arias LA, Habis R, et al.

    Journal of clinical apheresis 2024; (39(3)):e22112 doi:10.1002/jca.22112.

    PMID: 38634442
  25. 25

    Seronegative autoimmune encephalitis: clinical characteristics and factors associated with outcomes.

    Lee WJ, Lee HS, Kim DY, et al.

    Brain : a journal of neurology 2022; (145(10)):3509-3521 doi:10.1093/brain/awac166.

    PMID: 35512357
  26. 26

    Therapy response in seronegative versus seropositive autoimmune encephalitis.

    Berger B, Hauck S, Runge K, et al.

    Frontiers in immunology 2023; (14()):1196110 doi:10.3389/fimmu.2023.1196110.

    PMID: 37325671

This page is for informational purposes only and does not constitute medical advice or replace an evaluation by a qualified clinician. Seek urgent medical care for rapidly worsening confusion, a new seizure, inability to awaken, or fever with altered mental status.